- Home
- CTMX vs ARKO Comparison
CTMX vs ARKO Comparison
Compare CTMX & ARKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- ARKO
- Stock Information
- Founded
- CTMX 2008
- ARKO 1970
- Country
- CTMX United States
- ARKO United States
- Employees
- CTMX N/A
- ARKO N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- ARKO Oil Refining/Marketing
- Sector
- CTMX Health Care
- ARKO Energy
- Exchange
- CTMX Nasdaq
- ARKO Nasdaq
- Market Cap
- CTMX 444.3M
- ARKO 501.4M
- IPO Year
- CTMX 2015
- ARKO N/A
- Fundamental
- Price
- CTMX $2.40
- ARKO $4.66
- Analyst Decision
- CTMX Strong Buy
- ARKO Buy
- Analyst Count
- CTMX 2
- ARKO 4
- Target Price
- CTMX $5.00
- ARKO $7.19
- AVG Volume (30 Days)
- CTMX 1.5M
- ARKO 375.9K
- Earning Date
- CTMX 08-07-2025
- ARKO 08-06-2025
- Dividend Yield
- CTMX N/A
- ARKO 2.59%
- EPS Growth
- CTMX 128.27
- ARKO N/A
- EPS
- CTMX 0.49
- ARKO 0.03
- Revenue
- CTMX $147,557,000.00
- ARKO $8,488,413,000.00
- Revenue This Year
- CTMX N/A
- ARKO N/A
- Revenue Next Year
- CTMX N/A
- ARKO N/A
- P/E Ratio
- CTMX $4.97
- ARKO $178.13
- Revenue Growth
- CTMX 23.81
- ARKO N/A
- 52 Week Low
- CTMX $0.40
- ARKO $3.51
- 52 Week High
- CTMX $3.10
- ARKO $7.84
- Technical
- Relative Strength Index (RSI)
- CTMX 51.91
- ARKO 56.65
- Support Level
- CTMX $2.32
- ARKO $4.53
- Resistance Level
- CTMX $2.47
- ARKO $4.73
- Average True Range (ATR)
- CTMX 0.14
- ARKO 0.15
- MACD
- CTMX -0.01
- ARKO 0.02
- Stochastic Oscillator
- CTMX 17.89
- ARKO 85.11
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.